nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCB1—melanoma	0.107	1	CbGaD
Nifedipine—CYP1A1—Dacarbazine—melanoma	0.0675	0.142	CbGbCtD
Nifedipine—CYP2E1—Dacarbazine—melanoma	0.0521	0.11	CbGbCtD
Nifedipine—CYP1A2—Carmustine—melanoma	0.0497	0.105	CbGbCtD
Nifedipine—CYP1A2—Vemurafenib—melanoma	0.0393	0.083	CbGbCtD
Nifedipine—CYP3A4—Temozolomide—melanoma	0.0376	0.0794	CbGbCtD
Nifedipine—ABCC2—Docetaxel—melanoma	0.0362	0.0764	CbGbCtD
Nifedipine—CYP2D6—Vemurafenib—melanoma	0.0324	0.0684	CbGbCtD
Nifedipine—CYP1A2—Dacarbazine—melanoma	0.0301	0.0636	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0242	0.051	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—melanoma	0.0242	0.051	CbGbCtD
Nifedipine—ABCB1—Dactinomycin—melanoma	0.0228	0.0482	CbGbCtD
Nifedipine—CYP3A4—Vemurafenib—melanoma	0.0206	0.0435	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—melanoma	0.0181	0.0383	CbGbCtD
Nifedipine—CACNA1S—pes—melanoma	0.018	0.303	CbGeAlD
Nifedipine—ABCB1—Docetaxel—melanoma	0.0118	0.0249	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—melanoma	0.00707	0.0149	CbGbCtD
Nifedipine—CACNA1D—ear—melanoma	0.00415	0.0701	CbGeAlD
Nifedipine—CALM2—ear—melanoma	0.00252	0.0425	CbGeAlD
Nifedipine—CALM1—ear—melanoma	0.00251	0.0423	CbGeAlD
Nifedipine—KCNA1—retina—melanoma	0.00162	0.0274	CbGeAlD
Nifedipine—CYP1A1—skin epidermis—melanoma	0.00142	0.024	CbGeAlD
Nifedipine—CALM2—endothelium—melanoma	0.00135	0.0228	CbGeAlD
Nifedipine—CALM1—endothelium—melanoma	0.00134	0.0227	CbGeAlD
Nifedipine—CALM2—hair follicle—melanoma	0.00133	0.0224	CbGeAlD
Nifedipine—CALM2—blood vessel—melanoma	0.00125	0.021	CbGeAlD
Nifedipine—CALM1—blood vessel—melanoma	0.00124	0.0209	CbGeAlD
Nifedipine—CACNB2—retina—melanoma	0.00124	0.0209	CbGeAlD
Nifedipine—KCNA1—head—melanoma	0.000928	0.0157	CbGeAlD
Nifedipine—CALM2—neck—melanoma	0.000891	0.015	CbGeAlD
Nifedipine—CALM1—neck—melanoma	0.000887	0.015	CbGeAlD
Nifedipine—CALM3—eye—melanoma	0.000844	0.0143	CbGeAlD
Nifedipine—CALM3—retina—melanoma	0.000837	0.0141	CbGeAlD
Nifedipine—CACNB2—head—melanoma	0.000709	0.012	CbGeAlD
Nifedipine—CALM3—mammalian vulva—melanoma	0.00067	0.0113	CbGeAlD
Nifedipine—CACNA2D1—head—melanoma	0.000666	0.0112	CbGeAlD
Nifedipine—CALM2—eye—melanoma	0.000663	0.0112	CbGeAlD
Nifedipine—CALM1—eye—melanoma	0.00066	0.0111	CbGeAlD
Nifedipine—CALM2—retina—melanoma	0.000657	0.0111	CbGeAlD
Nifedipine—CALM1—retina—melanoma	0.000654	0.011	CbGeAlD
Nifedipine—CACNA1D—head—melanoma	0.00062	0.0105	CbGeAlD
Nifedipine—CALM2—skin of body—melanoma	0.000577	0.00974	CbGeAlD
Nifedipine—CALM1—skin of body—melanoma	0.000574	0.00969	CbGeAlD
Nifedipine—CACNA1C—head—melanoma	0.000572	0.00966	CbGeAlD
Nifedipine—CALM2—mammalian vulva—melanoma	0.000526	0.00888	CbGeAlD
Nifedipine—CACNA1H—lymph node—melanoma	0.000526	0.00888	CbGeAlD
Nifedipine—CALM1—mammalian vulva—melanoma	0.000524	0.00884	CbGeAlD
Nifedipine—ABCC3—head—melanoma	0.000521	0.00879	CbGeAlD
Nifedipine—CACNB2—lymph node—melanoma	0.000497	0.00838	CbGeAlD
Nifedipine—ABCB1—blood vessel—melanoma	0.000495	0.00836	CbGeAlD
Nifedipine—CACNA2D1—lymph node—melanoma	0.000466	0.00787	CbGeAlD
Nifedipine—CYP1A1—skin of body—melanoma	0.000441	0.00745	CbGeAlD
Nifedipine—CACNA1D—lymph node—melanoma	0.000434	0.00733	CbGeAlD
Nifedipine—CYP2B6—skin of body—melanoma	0.000429	0.00724	CbGeAlD
Nifedipine—CYP1A1—mammalian vulva—melanoma	0.000402	0.00679	CbGeAlD
Nifedipine—CACNA1C—lymph node—melanoma	0.000401	0.00676	CbGeAlD
Nifedipine—CALM2—head—melanoma	0.000376	0.00635	CbGeAlD
Nifedipine—CALM1—head—melanoma	0.000375	0.00632	CbGeAlD
Nifedipine—ABCC3—lymph node—melanoma	0.000364	0.00615	CbGeAlD
Nifedipine—CALM3—lymph node—melanoma	0.000336	0.00566	CbGeAlD
Nifedipine—Cardiac disorder—Temozolomide—melanoma	0.000308	0.00194	CcSEcCtD
Nifedipine—Arrhythmia—Carmustine—melanoma	0.000307	0.00194	CcSEcCtD
Nifedipine—Leukopenia—Bleomycin—melanoma	0.000307	0.00193	CcSEcCtD
Nifedipine—Dizziness—Vemurafenib—melanoma	0.000305	0.00193	CcSEcCtD
Nifedipine—Alopecia—Carmustine—melanoma	0.000304	0.00191	CcSEcCtD
Nifedipine—Angiopathy—Temozolomide—melanoma	0.000301	0.0019	CcSEcCtD
Nifedipine—Mental disorder—Carmustine—melanoma	0.000301	0.0019	CcSEcCtD
Nifedipine—Ataxia—Docetaxel—melanoma	0.0003	0.00189	CcSEcCtD
Nifedipine—Immune system disorder—Temozolomide—melanoma	0.0003	0.00189	CcSEcCtD
Nifedipine—Mediastinal disorder—Temozolomide—melanoma	0.000299	0.00189	CcSEcCtD
Nifedipine—Malnutrition—Carmustine—melanoma	0.000299	0.00189	CcSEcCtD
Nifedipine—Erythema—Carmustine—melanoma	0.000299	0.00189	CcSEcCtD
Nifedipine—Cough—Bleomycin—melanoma	0.000299	0.00189	CcSEcCtD
Nifedipine—Chills—Temozolomide—melanoma	0.000298	0.00188	CcSEcCtD
Nifedipine—Ill-defined disorder—Dactinomycin—melanoma	0.000296	0.00187	CcSEcCtD
Nifedipine—Anaemia—Dactinomycin—melanoma	0.000295	0.00186	CcSEcCtD
Nifedipine—Liver function test abnormal—Docetaxel—melanoma	0.000295	0.00186	CcSEcCtD
Nifedipine—Vomiting—Vemurafenib—melanoma	0.000293	0.00185	CcSEcCtD
Nifedipine—Alopecia—Temozolomide—melanoma	0.000293	0.00185	CcSEcCtD
Nifedipine—Myalgia—Bleomycin—melanoma	0.000292	0.00184	CcSEcCtD
Nifedipine—Chest pain—Bleomycin—melanoma	0.000292	0.00184	CcSEcCtD
Nifedipine—Orthostatic hypotension—Docetaxel—melanoma	0.000291	0.00184	CcSEcCtD
Nifedipine—ABCC2—lymph node—melanoma	0.000291	0.00492	CbGeAlD
Nifedipine—Rash—Vemurafenib—melanoma	0.000291	0.00184	CcSEcCtD
Nifedipine—Mental disorder—Temozolomide—melanoma	0.000291	0.00183	CcSEcCtD
Nifedipine—Dermatitis—Vemurafenib—melanoma	0.000291	0.00183	CcSEcCtD
Nifedipine—Back pain—Carmustine—melanoma	0.000289	0.00182	CcSEcCtD
Nifedipine—Headache—Vemurafenib—melanoma	0.000289	0.00182	CcSEcCtD
Nifedipine—Malnutrition—Temozolomide—melanoma	0.000289	0.00182	CcSEcCtD
Nifedipine—Erythema—Temozolomide—melanoma	0.000289	0.00182	CcSEcCtD
Nifedipine—Breast disorder—Docetaxel—melanoma	0.000288	0.00182	CcSEcCtD
Nifedipine—Discomfort—Bleomycin—melanoma	0.000288	0.00182	CcSEcCtD
Nifedipine—Malaise—Dactinomycin—melanoma	0.000288	0.00182	CcSEcCtD
Nifedipine—CYP1A1—head—melanoma	0.000288	0.00486	CbGeAlD
Nifedipine—Cramp muscle—Docetaxel—melanoma	0.000287	0.00181	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000287	0.00181	CcSEcCtD
Nifedipine—Leukopenia—Dactinomycin—melanoma	0.000286	0.0018	CcSEcCtD
Nifedipine—Dysgeusia—Temozolomide—melanoma	0.000283	0.00179	CcSEcCtD
Nifedipine—Confusional state—Bleomycin—melanoma	0.000282	0.00178	CcSEcCtD
Nifedipine—Vision blurred—Carmustine—melanoma	0.000282	0.00178	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000281	0.00178	CcSEcCtD
Nifedipine—Tremor—Carmustine—melanoma	0.00028	0.00177	CcSEcCtD
Nifedipine—CYP2B6—head—melanoma	0.00028	0.00472	CbGeAlD
Nifedipine—Oedema—Bleomycin—melanoma	0.00028	0.00176	CcSEcCtD
Nifedipine—Anaphylactic shock—Bleomycin—melanoma	0.00028	0.00176	CcSEcCtD
Nifedipine—Back pain—Temozolomide—melanoma	0.00028	0.00176	CcSEcCtD
Nifedipine—Anaemia—Carmustine—melanoma	0.000276	0.00174	CcSEcCtD
Nifedipine—Dysphagia—Docetaxel—melanoma	0.000276	0.00174	CcSEcCtD
Nifedipine—Agitation—Carmustine—melanoma	0.000275	0.00173	CcSEcCtD
Nifedipine—Nausea—Vemurafenib—melanoma	0.000274	0.00173	CcSEcCtD
Nifedipine—Thrombocytopenia—Bleomycin—melanoma	0.000274	0.00173	CcSEcCtD
Nifedipine—Vision blurred—Temozolomide—melanoma	0.000272	0.00172	CcSEcCtD
Nifedipine—Myalgia—Dactinomycin—melanoma	0.000272	0.00172	CcSEcCtD
Nifedipine—Bronchospasm—Docetaxel—melanoma	0.000271	0.00171	CcSEcCtD
Nifedipine—Tremor—Temozolomide—melanoma	0.000271	0.00171	CcSEcCtD
Nifedipine—Discomfort—Dactinomycin—melanoma	0.000269	0.0017	CcSEcCtD
Nifedipine—Angina pectoris—Docetaxel—melanoma	0.000269	0.00169	CcSEcCtD
Nifedipine—Ill-defined disorder—Temozolomide—melanoma	0.000268	0.00169	CcSEcCtD
Nifedipine—Leukopenia—Carmustine—melanoma	0.000268	0.00169	CcSEcCtD
Nifedipine—Anaemia—Temozolomide—melanoma	0.000267	0.00168	CcSEcCtD
Nifedipine—Anorexia—Bleomycin—melanoma	0.000266	0.00168	CcSEcCtD
Nifedipine—Agitation—Temozolomide—melanoma	0.000266	0.00168	CcSEcCtD
Nifedipine—Angioedema—Temozolomide—melanoma	0.000264	0.00167	CcSEcCtD
Nifedipine—CALM2—lymph node—melanoma	0.000264	0.00445	CbGeAlD
Nifedipine—CYP2E1—head—melanoma	0.000263	0.00443	CbGeAlD
Nifedipine—CALM1—lymph node—melanoma	0.000262	0.00443	CbGeAlD
Nifedipine—Hypotension—Bleomycin—melanoma	0.000261	0.00165	CcSEcCtD
Nifedipine—ABCB1—retina—melanoma	0.000261	0.00441	CbGeAlD
Nifedipine—Oedema—Dactinomycin—melanoma	0.000261	0.00164	CcSEcCtD
Nifedipine—Malaise—Temozolomide—melanoma	0.000261	0.00164	CcSEcCtD
Nifedipine—Vertigo—Temozolomide—melanoma	0.00026	0.00164	CcSEcCtD
Nifedipine—Leukopenia—Temozolomide—melanoma	0.000259	0.00163	CcSEcCtD
Nifedipine—Palpitations—Temozolomide—melanoma	0.000255	0.00161	CcSEcCtD
Nifedipine—Thrombocytopenia—Dactinomycin—melanoma	0.000255	0.00161	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000255	0.00161	CcSEcCtD
Nifedipine—Chest pain—Carmustine—melanoma	0.000255	0.00161	CcSEcCtD
Nifedipine—Myalgia—Carmustine—melanoma	0.000255	0.00161	CcSEcCtD
Nifedipine—Anxiety—Carmustine—melanoma	0.000254	0.0016	CcSEcCtD
Nifedipine—Cough—Temozolomide—melanoma	0.000252	0.00159	CcSEcCtD
Nifedipine—Paraesthesia—Bleomycin—melanoma	0.000251	0.00158	CcSEcCtD
Nifedipine—Weight increased—Docetaxel—melanoma	0.000251	0.00158	CcSEcCtD
Nifedipine—Weight decreased—Docetaxel—melanoma	0.00025	0.00157	CcSEcCtD
Nifedipine—Dyspnoea—Bleomycin—melanoma	0.000249	0.00157	CcSEcCtD
Nifedipine—Anorexia—Dactinomycin—melanoma	0.000249	0.00157	CcSEcCtD
Nifedipine—Confusional state—Carmustine—melanoma	0.000246	0.00155	CcSEcCtD
Nifedipine—Myalgia—Temozolomide—melanoma	0.000246	0.00155	CcSEcCtD
Nifedipine—Arthralgia—Temozolomide—melanoma	0.000246	0.00155	CcSEcCtD
Nifedipine—Anxiety—Temozolomide—melanoma	0.000245	0.00155	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000244	0.00154	CcSEcCtD
Nifedipine—Oedema—Carmustine—melanoma	0.000244	0.00154	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000244	0.00154	CcSEcCtD
Nifedipine—Discomfort—Temozolomide—melanoma	0.000243	0.00153	CcSEcCtD
Nifedipine—Decreased appetite—Bleomycin—melanoma	0.000243	0.00153	CcSEcCtD
Nifedipine—Dry mouth—Temozolomide—melanoma	0.000241	0.00152	CcSEcCtD
Nifedipine—Jaundice—Docetaxel—melanoma	0.00024	0.00151	CcSEcCtD
Nifedipine—Pain—Bleomycin—melanoma	0.000239	0.00151	CcSEcCtD
Nifedipine—Conjunctivitis—Docetaxel—melanoma	0.000239	0.00151	CcSEcCtD
Nifedipine—Thrombocytopenia—Carmustine—melanoma	0.000239	0.00151	CcSEcCtD
Nifedipine—Tachycardia—Carmustine—melanoma	0.000238	0.0015	CcSEcCtD
Nifedipine—Confusional state—Temozolomide—melanoma	0.000238	0.0015	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000238	0.0015	CcSEcCtD
Nifedipine—Anaphylactic shock—Temozolomide—melanoma	0.000236	0.00149	CcSEcCtD
Nifedipine—Oedema—Temozolomide—melanoma	0.000236	0.00149	CcSEcCtD
Nifedipine—Anorexia—Carmustine—melanoma	0.000233	0.00147	CcSEcCtD
Nifedipine—Hepatobiliary disease—Docetaxel—melanoma	0.000233	0.00147	CcSEcCtD
Nifedipine—Epistaxis—Docetaxel—melanoma	0.000232	0.00146	CcSEcCtD
Nifedipine—Nervous system disorder—Temozolomide—melanoma	0.000231	0.00146	CcSEcCtD
Nifedipine—Thrombocytopenia—Temozolomide—melanoma	0.000231	0.00146	CcSEcCtD
Nifedipine—Feeling abnormal—Bleomycin—melanoma	0.00023	0.00145	CcSEcCtD
Nifedipine—Agranulocytosis—Docetaxel—melanoma	0.000229	0.00145	CcSEcCtD
Nifedipine—Skin disorder—Temozolomide—melanoma	0.000229	0.00145	CcSEcCtD
Nifedipine—Hypotension—Carmustine—melanoma	0.000228	0.00144	CcSEcCtD
Nifedipine—Hyperhidrosis—Temozolomide—melanoma	0.000228	0.00144	CcSEcCtD
Nifedipine—Decreased appetite—Dactinomycin—melanoma	0.000227	0.00143	CcSEcCtD
Nifedipine—Fatigue—Dactinomycin—melanoma	0.000225	0.00142	CcSEcCtD
Nifedipine—Anorexia—Temozolomide—melanoma	0.000225	0.00142	CcSEcCtD
Nifedipine—Pain—Dactinomycin—melanoma	0.000223	0.00141	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Carmustine—melanoma	0.000222	0.0014	CcSEcCtD
Nifedipine—Urticaria—Bleomycin—melanoma	0.000222	0.0014	CcSEcCtD
Nifedipine—Haemoglobin—Docetaxel—melanoma	0.000222	0.0014	CcSEcCtD
Nifedipine—Rhinitis—Docetaxel—melanoma	0.000221	0.0014	CcSEcCtD
Nifedipine—Body temperature increased—Bleomycin—melanoma	0.000221	0.00139	CcSEcCtD
Nifedipine—Haemorrhage—Docetaxel—melanoma	0.000221	0.00139	CcSEcCtD
Nifedipine—Hepatitis—Docetaxel—melanoma	0.000221	0.00139	CcSEcCtD
Nifedipine—Insomnia—Carmustine—melanoma	0.000221	0.00139	CcSEcCtD
Nifedipine—Hypoaesthesia—Docetaxel—melanoma	0.00022	0.00139	CcSEcCtD
Nifedipine—Paraesthesia—Carmustine—melanoma	0.000219	0.00138	CcSEcCtD
Nifedipine—Pharyngitis—Docetaxel—melanoma	0.000219	0.00138	CcSEcCtD
Nifedipine—Urinary tract disorder—Docetaxel—melanoma	0.000218	0.00138	CcSEcCtD
Nifedipine—Dyspnoea—Carmustine—melanoma	0.000218	0.00137	CcSEcCtD
Nifedipine—Oedema peripheral—Docetaxel—melanoma	0.000217	0.00137	CcSEcCtD
Nifedipine—Somnolence—Carmustine—melanoma	0.000217	0.00137	CcSEcCtD
Nifedipine—Connective tissue disorder—Docetaxel—melanoma	0.000217	0.00137	CcSEcCtD
Nifedipine—Urethral disorder—Docetaxel—melanoma	0.000216	0.00137	CcSEcCtD
Nifedipine—Feeling abnormal—Dactinomycin—melanoma	0.000215	0.00136	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000215	0.00136	CcSEcCtD
Nifedipine—Insomnia—Temozolomide—melanoma	0.000213	0.00135	CcSEcCtD
Nifedipine—Gastrointestinal pain—Dactinomycin—melanoma	0.000213	0.00135	CcSEcCtD
Nifedipine—Visual impairment—Docetaxel—melanoma	0.000213	0.00134	CcSEcCtD
Nifedipine—Decreased appetite—Carmustine—melanoma	0.000212	0.00134	CcSEcCtD
Nifedipine—Paraesthesia—Temozolomide—melanoma	0.000212	0.00134	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Carmustine—melanoma	0.000211	0.00133	CcSEcCtD
Nifedipine—Dyspnoea—Temozolomide—melanoma	0.00021	0.00133	CcSEcCtD
Nifedipine—Somnolence—Temozolomide—melanoma	0.00021	0.00132	CcSEcCtD
Nifedipine—ABCB1—mammalian vulva—melanoma	0.000209	0.00353	CbGeAlD
Nifedipine—Erythema multiforme—Docetaxel—melanoma	0.000209	0.00132	CcSEcCtD
Nifedipine—Constipation—Carmustine—melanoma	0.000209	0.00132	CcSEcCtD
Nifedipine—Pain—Carmustine—melanoma	0.000209	0.00132	CcSEcCtD
Nifedipine—CYP2D6—head—melanoma	0.000208	0.00351	CbGeAlD
Nifedipine—Dyspepsia—Temozolomide—melanoma	0.000208	0.00131	CcSEcCtD
Nifedipine—Eye disorder—Docetaxel—melanoma	0.000206	0.0013	CcSEcCtD
Nifedipine—Body temperature increased—Dactinomycin—melanoma	0.000206	0.0013	CcSEcCtD
Nifedipine—Abdominal pain—Dactinomycin—melanoma	0.000206	0.0013	CcSEcCtD
Nifedipine—Hypersensitivity—Bleomycin—melanoma	0.000206	0.0013	CcSEcCtD
Nifedipine—Decreased appetite—Temozolomide—melanoma	0.000205	0.00129	CcSEcCtD
Nifedipine—Cardiac disorder—Docetaxel—melanoma	0.000205	0.00129	CcSEcCtD
Nifedipine—Flushing—Docetaxel—melanoma	0.000205	0.00129	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Temozolomide—melanoma	0.000204	0.00128	CcSEcCtD
Nifedipine—Fatigue—Temozolomide—melanoma	0.000203	0.00128	CcSEcCtD
Nifedipine—Pain—Temozolomide—melanoma	0.000202	0.00127	CcSEcCtD
Nifedipine—Constipation—Temozolomide—melanoma	0.000202	0.00127	CcSEcCtD
Nifedipine—CYP1A1—lymph node—melanoma	0.000202	0.0034	CbGeAlD
Nifedipine—Feeling abnormal—Carmustine—melanoma	0.000201	0.00127	CcSEcCtD
Nifedipine—Asthenia—Bleomycin—melanoma	0.000201	0.00127	CcSEcCtD
Nifedipine—Angiopathy—Docetaxel—melanoma	0.0002	0.00126	CcSEcCtD
Nifedipine—Gastrointestinal pain—Carmustine—melanoma	0.0002	0.00126	CcSEcCtD
Nifedipine—Immune system disorder—Docetaxel—melanoma	0.000199	0.00126	CcSEcCtD
Nifedipine—Mediastinal disorder—Docetaxel—melanoma	0.000199	0.00126	CcSEcCtD
Nifedipine—Chills—Docetaxel—melanoma	0.000198	0.00125	CcSEcCtD
Nifedipine—Pruritus—Bleomycin—melanoma	0.000198	0.00125	CcSEcCtD
Nifedipine—Arrhythmia—Docetaxel—melanoma	0.000197	0.00124	CcSEcCtD
Nifedipine—Alopecia—Docetaxel—melanoma	0.000195	0.00123	CcSEcCtD
Nifedipine—Feeling abnormal—Temozolomide—melanoma	0.000194	0.00123	CcSEcCtD
Nifedipine—Mental disorder—Docetaxel—melanoma	0.000193	0.00122	CcSEcCtD
Nifedipine—Body temperature increased—Carmustine—melanoma	0.000193	0.00122	CcSEcCtD
Nifedipine—Abdominal pain—Carmustine—melanoma	0.000193	0.00122	CcSEcCtD
Nifedipine—Gastrointestinal pain—Temozolomide—melanoma	0.000193	0.00122	CcSEcCtD
Nifedipine—Erythema—Docetaxel—melanoma	0.000192	0.00121	CcSEcCtD
Nifedipine—Malnutrition—Docetaxel—melanoma	0.000192	0.00121	CcSEcCtD
Nifedipine—Hypersensitivity—Dactinomycin—melanoma	0.000192	0.00121	CcSEcCtD
Nifedipine—Dysgeusia—Docetaxel—melanoma	0.000188	0.00119	CcSEcCtD
Nifedipine—Urticaria—Temozolomide—melanoma	0.000187	0.00118	CcSEcCtD
Nifedipine—Asthenia—Dactinomycin—melanoma	0.000187	0.00118	CcSEcCtD
Nifedipine—Body temperature increased—Temozolomide—melanoma	0.000186	0.00118	CcSEcCtD
Nifedipine—Abdominal pain—Temozolomide—melanoma	0.000186	0.00118	CcSEcCtD
Nifedipine—Back pain—Docetaxel—melanoma	0.000186	0.00117	CcSEcCtD
Nifedipine—Muscle spasms—Docetaxel—melanoma	0.000185	0.00117	CcSEcCtD
Nifedipine—Hypersensitivity—Carmustine—melanoma	0.00018	0.00113	CcSEcCtD
Nifedipine—Diarrhoea—Dactinomycin—melanoma	0.000178	0.00113	CcSEcCtD
Nifedipine—Vomiting—Bleomycin—melanoma	0.000178	0.00112	CcSEcCtD
Nifedipine—Anaemia—Docetaxel—melanoma	0.000178	0.00112	CcSEcCtD
Nifedipine—Rash—Bleomycin—melanoma	0.000176	0.00111	CcSEcCtD
Nifedipine—Dermatitis—Bleomycin—melanoma	0.000176	0.00111	CcSEcCtD
Nifedipine—Asthenia—Carmustine—melanoma	0.000175	0.0011	CcSEcCtD
Nifedipine—Hypersensitivity—Temozolomide—melanoma	0.000174	0.0011	CcSEcCtD
Nifedipine—Syncope—Docetaxel—melanoma	0.000172	0.00109	CcSEcCtD
Nifedipine—Leukopenia—Docetaxel—melanoma	0.000172	0.00109	CcSEcCtD
Nifedipine—Palpitations—Docetaxel—melanoma	0.00017	0.00107	CcSEcCtD
Nifedipine—Asthenia—Temozolomide—melanoma	0.000169	0.00107	CcSEcCtD
Nifedipine—Loss of consciousness—Docetaxel—melanoma	0.000169	0.00107	CcSEcCtD
Nifedipine—Cough—Docetaxel—melanoma	0.000168	0.00106	CcSEcCtD
Nifedipine—Diarrhoea—Carmustine—melanoma	0.000167	0.00105	CcSEcCtD
Nifedipine—Pruritus—Temozolomide—melanoma	0.000167	0.00105	CcSEcCtD
Nifedipine—Nausea—Bleomycin—melanoma	0.000166	0.00105	CcSEcCtD
Nifedipine—Vomiting—Dactinomycin—melanoma	0.000166	0.00105	CcSEcCtD
Nifedipine—Rash—Dactinomycin—melanoma	0.000164	0.00104	CcSEcCtD
Nifedipine—Chest pain—Docetaxel—melanoma	0.000164	0.00103	CcSEcCtD
Nifedipine—Myalgia—Docetaxel—melanoma	0.000164	0.00103	CcSEcCtD
Nifedipine—Arthralgia—Docetaxel—melanoma	0.000164	0.00103	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000162	0.00102	CcSEcCtD
Nifedipine—Dizziness—Carmustine—melanoma	0.000161	0.00102	CcSEcCtD
Nifedipine—Diarrhoea—Temozolomide—melanoma	0.000161	0.00102	CcSEcCtD
Nifedipine—Dry mouth—Docetaxel—melanoma	0.00016	0.00101	CcSEcCtD
Nifedipine—Confusional state—Docetaxel—melanoma	0.000158	0.000998	CcSEcCtD
Nifedipine—Anaphylactic shock—Docetaxel—melanoma	0.000157	0.000989	CcSEcCtD
Nifedipine—Oedema—Docetaxel—melanoma	0.000157	0.000989	CcSEcCtD
Nifedipine—Dizziness—Temozolomide—melanoma	0.000156	0.000984	CcSEcCtD
Nifedipine—Vomiting—Carmustine—melanoma	0.000155	0.000979	CcSEcCtD
Nifedipine—Nausea—Dactinomycin—melanoma	0.000155	0.000977	CcSEcCtD
Nifedipine—Shock—Docetaxel—melanoma	0.000154	0.000973	CcSEcCtD
Nifedipine—Rash—Carmustine—melanoma	0.000154	0.000971	CcSEcCtD
Nifedipine—Nervous system disorder—Docetaxel—melanoma	0.000154	0.00097	CcSEcCtD
Nifedipine—Dermatitis—Carmustine—melanoma	0.000154	0.00097	CcSEcCtD
Nifedipine—Thrombocytopenia—Docetaxel—melanoma	0.000154	0.000969	CcSEcCtD
Nifedipine—Tachycardia—Docetaxel—melanoma	0.000153	0.000966	CcSEcCtD
Nifedipine—Headache—Carmustine—melanoma	0.000153	0.000964	CcSEcCtD
Nifedipine—Skin disorder—Docetaxel—melanoma	0.000152	0.000961	CcSEcCtD
Nifedipine—Vomiting—Temozolomide—melanoma	0.00015	0.000946	CcSEcCtD
Nifedipine—ABCB1—head—melanoma	0.00015	0.00252	CbGeAlD
Nifedipine—Anorexia—Docetaxel—melanoma	0.000149	0.000943	CcSEcCtD
Nifedipine—Rash—Temozolomide—melanoma	0.000149	0.000938	CcSEcCtD
Nifedipine—Dermatitis—Temozolomide—melanoma	0.000149	0.000937	CcSEcCtD
Nifedipine—Headache—Temozolomide—melanoma	0.000148	0.000932	CcSEcCtD
Nifedipine—Hypotension—Docetaxel—melanoma	0.000147	0.000925	CcSEcCtD
Nifedipine—Nausea—Carmustine—melanoma	0.000145	0.000914	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000143	0.000901	CcSEcCtD
Nifedipine—Insomnia—Docetaxel—melanoma	0.000142	0.000895	CcSEcCtD
Nifedipine—Paraesthesia—Docetaxel—melanoma	0.000141	0.000888	CcSEcCtD
Nifedipine—Nausea—Temozolomide—melanoma	0.00014	0.000884	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—melanoma	0.00014	0.000882	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—melanoma	0.000139	0.00088	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—melanoma	0.000138	0.000871	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—melanoma	0.000136	0.00086	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—melanoma	0.000135	0.000854	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—melanoma	0.000135	0.000853	CcSEcCtD
Nifedipine—Pain—Docetaxel—melanoma	0.000134	0.000846	CcSEcCtD
Nifedipine—Constipation—Docetaxel—melanoma	0.000134	0.000846	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—melanoma	0.000129	0.000815	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—melanoma	0.000128	0.000809	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—melanoma	0.000124	0.000782	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—melanoma	0.000124	0.000782	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—melanoma	0.000116	0.000729	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—melanoma	0.000113	0.00071	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—melanoma	0.000111	0.0007	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—melanoma	0.000107	0.000677	CcSEcCtD
Nifedipine—ABCB1—lymph node—melanoma	0.000105	0.00177	CbGeAlD
Nifedipine—Dizziness—Docetaxel—melanoma	0.000104	0.000654	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—melanoma	9.97e-05	0.000629	CcSEcCtD
Nifedipine—Rash—Docetaxel—melanoma	9.89e-05	0.000624	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—melanoma	9.88e-05	0.000623	CcSEcCtD
Nifedipine—Headache—Docetaxel—melanoma	9.82e-05	0.00062	CcSEcCtD
Nifedipine—Nausea—Docetaxel—melanoma	9.32e-05	0.000588	CcSEcCtD
Nifedipine—Nisoldipine—ABCB1—melanoma	4.69e-05	0.238	CrCbGaD
Nifedipine—Nitrendipine—ABCB1—melanoma	4.38e-05	0.223	CrCbGaD
Nifedipine—Amlodipine—ABCB1—melanoma	3.78e-05	0.192	CrCbGaD
Nifedipine—Felodipine—ABCB1—melanoma	3.49e-05	0.178	CrCbGaD
Nifedipine—Nicardipine—ABCB1—melanoma	3.32e-05	0.169	CrCbGaD
Nifedipine—CALM1—Immune System—STAT3—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAP2K1—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—melanoma	2.6e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK1—melanoma	2.59e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK1—melanoma	2.59e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—melanoma	2.59e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—melanoma	2.59e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CD—melanoma	2.58e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—melanoma	2.58e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—melanoma	2.58e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK3—melanoma	2.57e-06	1.28e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—melanoma	2.57e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CB—melanoma	2.56e-06	1.27e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—melanoma	2.53e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—melanoma	2.53e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAP2K1—melanoma	2.52e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAP2K1—melanoma	2.52e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—melanoma	2.51e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—melanoma	2.5e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—melanoma	2.5e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—melanoma	2.49e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—melanoma	2.49e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—melanoma	2.49e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—melanoma	2.49e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—melanoma	2.48e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGF2—melanoma	2.47e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK1—melanoma	2.45e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—melanoma	2.45e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—melanoma	2.45e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—melanoma	2.45e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—melanoma	2.42e-06	1.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—melanoma	2.4e-06	1.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—melanoma	2.4e-06	1.2e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—melanoma	2.4e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—melanoma	2.4e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—melanoma	2.4e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGF2—melanoma	2.39e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGF2—melanoma	2.39e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—melanoma	2.39e-06	1.19e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—melanoma	2.38e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK1—melanoma	2.37e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK1—melanoma	2.37e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—melanoma	2.37e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—melanoma	2.37e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—melanoma	2.34e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—melanoma	2.34e-06	1.16e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—melanoma	2.34e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—melanoma	2.34e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—melanoma	2.33e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—melanoma	2.32e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—melanoma	2.32e-06	1.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—melanoma	2.32e-06	1.15e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—melanoma	2.31e-06	1.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—melanoma	2.31e-06	1.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—melanoma	2.31e-06	1.15e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—melanoma	2.3e-06	1.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—melanoma	2.3e-06	1.14e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—melanoma	2.28e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—melanoma	2.28e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—melanoma	2.28e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK1—melanoma	2.26e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—melanoma	2.26e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—melanoma	2.25e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—melanoma	2.25e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—melanoma	2.25e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—melanoma	2.25e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—melanoma	2.25e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—melanoma	2.24e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—melanoma	2.24e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—melanoma	2.24e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—melanoma	2.24e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—melanoma	2.23e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—melanoma	2.23e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.23e-06	1.11e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—melanoma	2.21e-06	1.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—melanoma	2.21e-06	1.1e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—melanoma	2.21e-06	1.1e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—melanoma	2.21e-06	1.1e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—melanoma	2.19e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK1—melanoma	2.19e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK1—melanoma	2.19e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—melanoma	2.19e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—melanoma	2.19e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—melanoma	2.18e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—melanoma	2.18e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—melanoma	2.18e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—melanoma	2.16e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—melanoma	2.16e-06	1.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—melanoma	2.15e-06	1.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—melanoma	2.13e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—melanoma	2.13e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—melanoma	2.12e-06	1.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—melanoma	2.11e-06	1.05e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PRKCA—melanoma	2.1e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—melanoma	2.09e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—melanoma	2.09e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—melanoma	2.09e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—melanoma	2.08e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—melanoma	2.08e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ERCC2—melanoma	2.08e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—melanoma	2.07e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—melanoma	2.07e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—melanoma	2.06e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—melanoma	2.06e-06	1.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—melanoma	2.06e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—melanoma	2.05e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—melanoma	2.05e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—melanoma	2.05e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—melanoma	2.05e-06	1.02e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—melanoma	2.05e-06	1.02e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—melanoma	2.04e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—melanoma	2.03e-06	1.01e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—melanoma	2.02e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—melanoma	2.02e-06	1e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—melanoma	2e-06	9.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—melanoma	2e-06	9.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—melanoma	2e-06	9.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—melanoma	2e-06	9.95e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—melanoma	2e-06	9.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—melanoma	1.99e-06	9.9e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—melanoma	1.99e-06	9.9e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—melanoma	1.97e-06	9.77e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—melanoma	1.96e-06	9.75e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—melanoma	1.96e-06	9.73e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—melanoma	1.95e-06	9.7e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—melanoma	1.95e-06	9.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—melanoma	1.95e-06	9.7e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—melanoma	1.95e-06	9.67e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NFKB1—melanoma	1.94e-06	9.63e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—melanoma	1.93e-06	9.6e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—melanoma	1.93e-06	9.6e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—melanoma	1.92e-06	9.56e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—melanoma	1.91e-06	9.48e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—melanoma	1.91e-06	9.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—melanoma	1.9e-06	9.45e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—melanoma	1.9e-06	9.45e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—melanoma	1.9e-06	9.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—melanoma	1.9e-06	9.43e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—melanoma	1.9e-06	9.43e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—melanoma	1.89e-06	9.41e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—melanoma	1.89e-06	9.41e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—melanoma	1.89e-06	9.39e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—melanoma	1.89e-06	9.38e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—melanoma	1.89e-06	9.38e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—melanoma	1.88e-06	9.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—melanoma	1.88e-06	9.36e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—melanoma	1.88e-06	9.35e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NFKB1—melanoma	1.87e-06	9.31e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NFKB1—melanoma	1.87e-06	9.31e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—melanoma	1.87e-06	9.29e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—melanoma	1.86e-06	9.26e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—melanoma	1.85e-06	9.17e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—melanoma	1.84e-06	9.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—melanoma	1.84e-06	9.13e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—melanoma	1.82e-06	9.04e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—melanoma	1.82e-06	9.04e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—melanoma	1.81e-06	9.02e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—melanoma	1.76e-06	8.77e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—melanoma	1.76e-06	8.74e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—melanoma	1.76e-06	8.72e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—melanoma	1.76e-06	8.72e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—melanoma	1.74e-06	8.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—melanoma	1.74e-06	8.63e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—melanoma	1.74e-06	8.63e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—melanoma	1.74e-06	8.62e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—melanoma	1.71e-06	8.49e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—melanoma	1.7e-06	8.45e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—melanoma	1.7e-06	8.45e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—melanoma	1.69e-06	8.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—melanoma	1.68e-06	8.37e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—melanoma	1.68e-06	8.37e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—melanoma	1.68e-06	8.35e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—melanoma	1.68e-06	8.35e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—melanoma	1.68e-06	8.35e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—melanoma	1.68e-06	8.35e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—melanoma	1.68e-06	8.34e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—melanoma	1.68e-06	8.34e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—melanoma	1.66e-06	8.27e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—melanoma	1.66e-06	8.26e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—melanoma	1.65e-06	8.21e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—melanoma	1.65e-06	8.2e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—melanoma	1.65e-06	8.19e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—melanoma	1.64e-06	8.16e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—melanoma	1.64e-06	8.16e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—melanoma	1.63e-06	8.1e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—melanoma	1.62e-06	8.04e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—melanoma	1.61e-06	8.03e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—melanoma	1.61e-06	8e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—melanoma	1.61e-06	8e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—melanoma	1.6e-06	7.96e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—melanoma	1.59e-06	7.9e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—melanoma	1.59e-06	7.9e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—melanoma	1.58e-06	7.87e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK1—melanoma	1.58e-06	7.86e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—melanoma	1.58e-06	7.86e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—melanoma	1.56e-06	7.78e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—melanoma	1.56e-06	7.78e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—melanoma	1.56e-06	7.74e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—melanoma	1.55e-06	7.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—melanoma	1.55e-06	7.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK1—melanoma	1.53e-06	7.61e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK1—melanoma	1.53e-06	7.61e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—melanoma	1.53e-06	7.61e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—melanoma	1.53e-06	7.61e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—melanoma	1.49e-06	7.43e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—melanoma	1.45e-06	7.19e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—melanoma	1.45e-06	7.19e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—melanoma	1.44e-06	7.17e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—melanoma	1.43e-06	7.1e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—melanoma	1.42e-06	7.08e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—melanoma	1.41e-06	7e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—melanoma	1.38e-06	6.85e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—melanoma	1.37e-06	6.82e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—melanoma	1.35e-06	6.71e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—melanoma	1.35e-06	6.7e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—melanoma	1.34e-06	6.67e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—melanoma	1.33e-06	6.6e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—melanoma	1.33e-06	6.6e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—melanoma	1.33e-06	6.6e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—melanoma	1.3e-06	6.45e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—melanoma	1.3e-06	6.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—melanoma	1.29e-06	6.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—melanoma	1.29e-06	6.39e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—melanoma	1.27e-06	6.33e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—melanoma	1.27e-06	6.31e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—melanoma	1.26e-06	6.25e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—melanoma	1.25e-06	6.19e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—melanoma	1.24e-06	6.19e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—melanoma	1.23e-06	6.11e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—melanoma	1.23e-06	6.11e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—melanoma	1.22e-06	6.04e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—melanoma	1.18e-06	5.85e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—melanoma	1.18e-06	5.85e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—melanoma	1.17e-06	5.83e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—melanoma	1.17e-06	5.8e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—melanoma	1.16e-06	5.78e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—melanoma	1.12e-06	5.58e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—melanoma	1.09e-06	5.4e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—melanoma	1.09e-06	5.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—melanoma	1.09e-06	5.39e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—melanoma	1.02e-06	5.05e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—melanoma	9.94e-07	4.94e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—melanoma	9.58e-07	4.76e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—melanoma	9.5e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—melanoma	8.12e-07	4.03e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—melanoma	7.67e-07	3.81e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—melanoma	6.26e-07	3.11e-06	CbGpPWpGaD
